To include your compound in the COVID-19 Resource Center, submit it here.

Oncolytic duos and Dx

Several companies are looking for therapeutic combinations that change how oncolytic viruses interact with cancer cells.

At least two companies, Oncolys BioPharma Inc. and Oryx GmbH & Co. KG, are

Read the full 298 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE